Our Lab Services as a contract laboratory cover analytical services for Biologics (ATMPs, Biopharmaceuticals, Originator products, Biosimilar Candidates, Biosimilars, Blood and blood components, Vaccines), Chemicals and Excipients from early stages of product development (non-clinical, clinical) until market release testing for Pharma and Biotech companies as well as storage facilities enabling long term stability studies.
Also all types of microbiological analysis can can be conducted.
We are GMP & GLP-certified and G(C)LP-compliant.
CONTACT us, we are looking forward to support your projects and meet your analysis needs.
VelaLabs collaborates with the St. Anna Children’s Hospital, which provides comprehensive care for the children and young people entrusted to them: The concept of the hospital integrates the treatment of patients according to the latest state of medical knowledge, care as support for self-care in close cooperation with caregivers and the psychosocial care of the patients and their families.
VelaLabs is member of Life Science Austria Vienna Region (LISA VR), which provides support and advice to start-ups and high-technology companies.
Vela is partner of the network and cluster of Human Technology Styria.
Biomedica is a leading distributor of medical devices, in-vitro diagnostics and products for Life Sciences. VelaLabs and Biomedica collaborate regarding the implementation, use, marketing and testing services of the GlycoTechnica LecChip technology.
Evercyte offers immortalized cells that retain their primary-like human cell characteristics. VelaLabs and Evercyte have a cooperation for the usage of immortalized cell lines for biosimilar characterization.
Long-term partners of VelaLabs are the Department of Clinical Pharmacology and the Coordination Center for Clinical Studies (KKS) both from the Medical University of Vienna.
BLS – Analytik GmbH & co. KG is a Tentamus laboratory, focusing on the physical, physical-chemical and chemical testing and analysis of pharmaceuticals, food, feed and cosmetic products. BLS is a fully GMP, FDA, and ISO 17025 inspected and approved laboratory.
BAV Institute is an accredited contract laboratory offering hygiene and quality control services in the fields of food, cosmetics, and pharma. In addition to microbial testing, the company specializes in on-site consulting and training.
Protagen Protein Services (PPS) is a leading CRO in protein analytics and its application to GMP-compliant characterization of protein therapeutics. PPS supports multiple biosimilar developers in achieving and demonstrating biosimilarity. Many years of experience of PPS in business and a comprehensive spectrum of validated analytical methods ensure highest quality for customers in the pharmaceutical, biotechnology and life science industry.
MPL Mikrobiologisches Prüflabor GmbH is the GMP certified partner of VelaLabs for microbiological analytics.
BIOTECH AUSTRIA is the specific representation of the Austrian biotechnology industry. The goals are the targeted bundling of the interests of the industry in order to act with a powerful voice towards politics and society, the improvement of the framework conditions and the realization of synergy effects.
VelaLabs’s customers include some of the biggest names in Pharma and Biotech.
Our focused, customer – orientated approach, a highly motivated team and a broad expertise in analytical development and quality control led to trusting relationships meeting the requirements of our customers for more than 10 years.
VelaLabs in Biotechnologie Jahrbuch N34
Spreading out wings – VelaLabs in Biotechnologie Jahrbuch N34 VelaLabs is one of 151 Biotechnology companies in Austria offering analytical laboratory services from medication development to market release. The company figures reflect the positive trend of the industry in terms of revenue, number of projects and employee growth. Already serving customers from all over
... Continued
Bevacizumab and its biosimilars – treating cancer
FACES OF CANCER Over 100 types of cancer – a group of diseases involving abnormal cell growth with potential of invading and spreading into other parts of the body – affect about 100 million people worldwide, with over 8 million deaths anually. The risk of cancer increases with age and is more likely in developed
... Continued
Biosimilar insulins – potential to provide safe, high quality and cost efficient treatment options
Diabetes disease An estimated 463 million people were suffering from diabetes worldwide in 2019. Type 2 diabetes begins with insulin resistance and counts for 90% of cases. Type 1 diabetes results from failure of the pancreas to produce enough insulin due to loss of beta cells. The main goal of diabetes management as far as possible is
... Continued
Aducanumab – first new treatment approved for Alzheimer’s since 2003
Alzheimer disease: Alzheimer’s is responsible for 60% of the world’s estimated 50 million dementias. The heterogeneity of the disease makes Alzheimer’s diagnosis and counting the total number of affected people difficult. Every fifth patient has an atypical Alzheimer’s disease, which is often not recognized This progressive neurodegenerative disease starts with microscopic changes in the brain
... Continued
VISIT the labs – discover Velalabs’ ligand binding services
August 2021: For the characterization of proteins, interaction analysis is essential. See which methods we apply in our laboratory to investigate binding interactions of molecules. Resulting parameters include kinetics, affinity, specificity, concentration and content. Pharma and Biotech companies can rely on broad experience in providing tailormade applications to help understand binding interactions in detail. Take a look into the laboratories of VelaLabs! Click HERE for further information on
... Continued
VelaLabs extends its pharmaceutical bacteriology testing by MALDI-TOF
June 2021: With MALDI-TOF mass spectrometry (Matrix Assisted Laser Desorption lonization – Time of Flight) VelaLabs extends its’ method portfolio for germ identification in the field of microbiology. MALDI-TOF method The method combines matrix-assisted laser desorption ionization (MALDI) with time of flight (TOF) of released ions for mass spectrometry. The bacterial species is identified
... Continued
